Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Michele D. Picard"'
Autor:
Henry C. Marsh, Michele D. Picard, Jun Qian, David T. Beattie, David Zopf, Lawrence J. Thomas, Tom Stevenson, Krishnasamy Panneerselvam, Russell A. Hammond, Charles W. Rittershaus, Bi Xu, Robert Bayer
Publikováno v:
Glycobiology. 14:883-893
Recombinant soluble human complement receptor type 1 (sCR1) is a highly glycosylated glycoprotein intended for use as a drug to treat ischemia-reperfusion injury and other complement-mediated diseases and injuries. sCR1-sLe(x) produced in the FT-VI-e
Autor:
David P. Miller, Una S. Ryan, Russell A. Hammond, Henry C. Marsh, Lawrence J. Thomas, Christopher M. Honan, Allan D. Callow, Constance D. Emmett, Carolyn L. Pettey, Michele D. Picard, David T. Beattie, Charles W. Rittershaus, Hedy Adari
Publikováno v:
Arteriosclerosis, Thrombosis, and Vascular Biology. 20:2106-2112
Abstract —Using a vaccine approach, we immunized New Zealand White rabbits with a peptide containing a region of cholesteryl ester transfer protein (CETP) known to be required for neutral lipid transfer function. These rabbits had significantly red
Publikováno v:
Vaccine. 30(29)
A comprehensive proteomic screening technology was previously used to characterize T cell responses to Chlamydia trachomatis infection. In this study, we demonstrated that T cells specific for protein antigens identified through this comprehensive te
Autor:
Michele D. Picard, Alan M. Sugar
Publikováno v:
Antonie van Leeuwenhoek. 57:21-27
We studied the mechanisms of adherence of Blastomyces dermatitidis conidia to murine bronchoalveolar macrophages and the ability of the conidia to elicit an increase in macrophage O2- production, using an avirulent fungal strain. The number of cell a
Publikováno v:
Biotechnology and applied biochemistry. 31(1)
We sought to produce a complement inhibitory protein possessing oligosaccharides specifically modified to contain the sialyl Lewis x (sLe(x)) moiety. This modified glycoprotein could combine anti-complement activity with the ability to inhibit select
Publikováno v:
The Journal of infectious diseases. 171(6)
The effects of human bronchoalveolar macrophages (BAMs) on Blastomyces dermatitidis conidia were investigated. Macrophage monolayers were incubated for 5 days with or without interferon (IFN)-gamma or macrophage colony-stimulating factor (M-CSF) befo
Autor:
Lawrence J. Thomas, David T. Beattie, Michele D. Picard, Bi Xu, Charles W. Rittershaus, Henry C. Marsh, Russell A. Hammond, Jun Qian, Tom Stevenson, David Zopf, Robert J. Bayer
Publikováno v:
Glycobiology; Oct2004, Vol. 14 Issue 10, p883-893, 11p